phrykt

BioStem Technologies, Inc. (BSEM): who owns it and who trades it

As of Nov 16, 2026, no open-market insider purchases or sales of BSEM were reported in the last 12 months. 1 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Insider trades

No BSEM insider reported an open-market purchase or sale in the last 12 months.

Purchases, 12 months
$0
0 trades, 0 people
Sales, 12 months
$0
0 trades, 0 people
Sales under a 10b5-1 plan
–
Share of sale value
Latest trade
–
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

BSEM short interest

Low short interest. 1.6% of BSEM shares are sold short: about 1 share in 62. Over the last 12 reports the number of shares short went down 26%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 286,950 BSEM shares were sold short, 1.6% of the shares outstanding, down 14.0% from the report before. At the average daily volume of 187,457 shares, buying them all back would take about 1.5 trading days (days to cover).

Shares short, % of all shares

1.61%Aug 14Oct 303.49%

Days to cover

1.5May 15Oct 306.3

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 2026286,9501.61%-14%187,4571.5
Oct 15, 2026333,8431.87%+239%110,4343.0
Sep 30, 202698,4530.55%-26%226,0361.0
Sep 15, 2026133,9220.75%+12%133,3541.0
Aug 31, 2026119,2030.67%-78%89,1691.3
Aug 14, 2026554,2333.11%+42%153,3653.6
Jul 31, 2026391,682–+1%86,2524.5
Jul 15, 2026389,630–+2%69,7585.6
Jun 30, 2026382,667–-0%86,4754.4
Jun 15, 2026383,486–+0%110,3893.5
May 29, 2026383,029–-2%164,4362.3
May 15, 2026389,963–+2%140,6882.8

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

BioStem Technologies company events

BioStem Technologies filed 4 reports on Form 8-K in the last 12 months, all of them routine, such as results and vote reports. The latest was on Sep 30, 2026.

  1. Sep 30, 2026AgreementBioStem Technologies, Inc. entered into a securities purchase agreement with certain institutional investors, pursuant to which the Company issued and sold in a private placement an aggregate of 735,296 shares of the Company’s common stock, par value $0.001 per share, at a purchase price of $4.08… Filing
  2. Sep 18, 2026AgreementBioStem Technologies, Inc., a Florida corporation entered into a common stock purchase agreement and a related registration rights agreement, dated as of September 18, 2026, with Roth Principal Investments, LLC. Filing
  3. Aug 12, 2026ResultsReleased financial results. Filing
  4. Aug 7, 2026AnnouncementBioStem Technologies, Inc., announced that its shares of common stock, par value $0.001, have been approved by The Nasdaq Stock Market LLC for listing on The Nasdaq Capital Market. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

BioStem Technologies financials

Famous investors that hold BSEM

1 of the 50 well-known investors we track reported holding BSEM in their latest 13F filing. The largest position is Israel Englander's, worth $74.1K.

FundQuarterSharesValueOf portfolioChange
Israel Englander · Millennium ManagementQ3 202623,990$74.1K0.0%New

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 6 filings named BSEM in the last 120 days.

FiledHolderFormStake
Nov 10, 2026Andrew Van Vurst13G18.4%
Nov 10, 2026Jason Matuszewski13G17.4%
Nov 10, 2026Jason Matuszewski13G17.4%
Nov 10, 2026Andrew Van Vurst13G18.4%
Nov 5, 2026The PNC Financial Services Group, Inc.13G10.4%
Nov 5, 2026The PNC Financial Services Group, Inc.13G10.4%

Questions about BioStem Technologies, Inc. (BSEM) stock

Are BSEM insiders buying or selling?

No BSEM insider reported an open-market purchase or sale on Form 4 in the last 12 months. Share awards, option exercises and gifts are not counted.

What is the short interest in BSEM?

As of Oct 30, 2026, 286,950 BSEM shares were sold short, 1.6% of the shares outstanding, down 14.0% from the report before. At the average daily volume of 187,457 shares, buying them all back would take about 1.5 trading days (days to cover). See the history.

Which famous investors hold BSEM?

1 of the 50 well-known investors we track reported BSEM in their latest 13F filing, including Israel Englander. The largest position is worth $74.1K. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.